Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion

Biorestorative Therapies (BRTX) Earnings Date, Estimates & Call Transcripts

Biorestorative Therapies logo
$0.21 +0.02 (+7.77%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$0.21 +0.01 (+2.88%)
As of 05/22/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biorestorative Therapies Earnings Summary

Biorestorative Therapies released Q1 2026 earnings on May 14, 2026, reporting an EPS of -$0.19, which topped the consensus estimate of -$0.20 by $0.01. Quarterly revenue was reported to be $0.02 million, below analysts' expectations of $0.31 million. With a trailing EPS of -$1.07, Biorestorative Therapies' earnings are expected to grow next year, from ($0.66) to ($0.52) per share.

Upcoming Q2
Earnings Date
Aug. 11After Market ClosesEstimated
Consensus EPS
(May. 14)
-$0.20
Actual EPS
(May. 14)
-$0.19 Beat By $0.01
Actual Revenue
(May. 14)
$0.02M

Q1 2026 Earnings Resources

BRTX Upcoming Earnings

Biorestorative Therapies' next earnings date is estimated for Tuesday, August 11, 2026, based on past reporting schedules.

Get Biorestorative Therapies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biorestorative Therapies and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Biorestorative Therapies Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.66) EPS
Next Year EPS Consensus Estimate
($0.52) EPS

Biorestorative Therapies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026
(Estimated)
--------
5/14/2026Q1 2026-$0.20-$0.19+$0.01-$0.12$0.31M$0.02M
3/26/2026Q4 2025-$0.37-$0.37--$0.32$0.15M$0.02M
11/12/2025Q3 2025-$0.38-$0.38--$0.33$0.46M$0.01M
8/12/2025Q2 2025-$0.41-$0.30+$0.11-$0.30$0.34M$0.30M
5/14/2025Q1 2025-$0.32-$0.56 -$0.24-$0.64$0.38M$0.03M
3/27/2025Q4 2024-$0.27-$0.20+$0.07-$0.20$0.48M$0.50M
11/12/2024--$0.35-$0.13+$0.22-$0.13$0.30M$0.23M
8/13/2024Q2 2024-$0.56-$0.50+$0.06-$0.50$0.03M$0.09M
8/13/2024Q2 2024-$0.56-$0.50+$0.06-$0.50$0.03M$0.09M
6/11/2024Q1 2024-$0.51-$0.53 -$0.02-$0.73$0.03M$0.04M
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
6/11/2024Q1 2024-$0.51-$0.53 -$0.02-$0.73$0.03M$0.04M

Data powered by Fiscal.ai.

Biorestorative Therapies Earnings - Frequently Asked Questions

Biorestorative Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2026 based off last year's report dates. Learn more on BRTX's earnings history.

In the previous quarter, Biorestorative Therapies (NASDAQ:BRTX) reported ($0.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.01. Learn more on analysts' earnings estimate vs. BRTX's actual earnings.

Biorestorative Therapies (NASDAQ:BRTX) has a recorded annual revenue of $360,000.00.

Biorestorative Therapies (NASDAQ:BRTX) has a recorded net income of -$14.24 million. BRTX has generated -$1.07 earnings per share over the last four quarters.

Biorestorative Therapies' earnings are expected to grow from ($0.66) per share to ($0.52) per share in the next year.


This page (NASDAQ:BRTX) was last updated on 5/24/2026 by MarketBeat.com Staff.
From Our Partners